All Pharmaceutical Articles
  • Healthcare price transparency: A tough pill to swallow

    Jason Poquette Healthcare Administration

    ​In a 2014 Wall Street Journal articleNo matter what side of the political fence you sit on, healthcare price transparency is a factor that most feel is important. President-elect Donald Trump included a reference to this in his healthcare reform platform, stating that he would "require price transparency from all healthcare providers, especially doctors and healthcare organizations like clinics and hospitals." Similarly, Hilary Clinton acknowledged the importance of this issue, stating on her website that "we must do more to shine a light on healthcare prices."

  • How can we lower drug costs in 2017?

    Dr. Abimbola Farinde Pharmaceutical

    ​For many Americans, news stories about increasing prescription drug prices have become commonplace. The costs of prescription drugs within group health plans have continued to increase at double digit rates in recent years, and experts are forecasting more of the same for 2017.

  • High drug costs: The other side of the coin

    Jason Poquette Pharmaceutical

    There are two sides to every coin. And when it comes to the price of prescription drugs, it would appear the media (and many pharma news sites) are really only interested in looking at the high-cost, scandal-ridden, skyrocketing-price side of this particular penny. It seems like a game of "heads I win, tails you lose."

  • Senators call for investigation into insulin price spikes

    Dr. Abimbola Farinde Pharmaceutical

    The United States is known for paying the ​highest costs of prescription drugs in the world, especially when compared to nations such as Japan and Canada. The issue of increasing prescription drug prices has gained much attention over the last few years both from the general public as well as government officials who desire to change this pattern. This topic has been brought to the forefront of conversation thanks to recent examples like Daraparim and EpiPen, which observed dramatic price increases from their respective manufacturers.

  • Trump presidency likely to bring major changes to healthcare

    Joan Spitrey Healthcare Administration

    Now that the 2016 election season has come to a close, there really is only one thing most are agreeing on — they are glad it's finally over. Since the first political ad aired more than 500 days ago, the race to the White House has been one of the most divisive and hotly contested campaigns in modern history.

  • The top 5 concerns for pharmacists today

    Jason Poquette Pharmaceutical

    "This is Dr. Frasier Crane, and I'm listening." So started many of the popular sitcom episodes of Frasier which spanned more than a decade. The truth is, while I spend much of my day talking, presenting, teaching and writing, I'm listening, too. And I love hearing from my fellow pharmacists and pharmacy students about their current views and concerns for our profession.

  • CDC takes aim at diabetes with prevention programs

    Dr. Abimbola Farinde Medical & Allied Healthcare

    Diabetes is recognized as a chronic, long-term condition that can cause high blood sugar levels. In 2013, it was reported that approximately 382 million people throughout the world were diagnosed with diabetes. The number of individuals diagnosed with diabetes continues to grow, but steps are being taken to identify early risk and proper management of the condition.

  • Most results from late-stage trials of failed drugs go unpublished

    Lynn Hetzler Pharmaceutical

    ​About half of all investigational drugs fail late-stage clinical development, according to a new study published in the Journal of the American Medical Association (JAMA), and the results of most of these failed studies never reach print. Unfortunately, the lack of reports of failed drugs hinders the advancement of medical knowledge, in that failures can actually inform clinical practice, shape regulatory decisions and support future studies.

  • Health systems science: The third pillar of medical education

    Christina Thielst Healthcare Administration

    ​The American Medical Association (AMA) will soon release their new "Health Systems Science" textbook to help prepare students to become physicians who understand how patients receive and access care in today's healthcare systems. The focus of the text is on value in healthcare, patient safety, quality improvement, teamwork and team science, leadership, clinical informatics, population health, socio-ecological determinants of health, healthcare policy and healthcare economics.

  • California sets the bar for violence against healthcare workers

    Joan Spitrey Healthcare Administration

    When most healthcare workers head into their jobs, the threat of violence is usually not a major concern. It was not really on my radar when I went to work one night in the emergency department (ED) of a busy New York City hospital. Sure, we saw some upset patients and family, but that is just par for the course when working in the ED. After all, our doors were locked, and we had multiple security officers stationed throughout our busy ED. However, this night was going to be different.